Elsevier Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Rosenberg
    Rosenberg
  5. Iyer
    Iyer
  6. Solit
    Solit
  7. Feldman
    Feldman
  8. Morris
    Morris
  9. Slovin
    Slovin
  10. Voss
    Voss

Groups

  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)
  7. Urology (54)
  8. Hematologic Malignancies, Division of (49)
  9. Human Oncology and Pathogenesis Program (49)
  10. Department of Pathology and Laboratory Medicine (46)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (245)
  2. Meeting Abstract (120)
  3. Review (7)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)

More Groups

People
  1. Robert Motzer (89)
  2. Howard Scher (72)
  3. Dean Bajorin (50)
  4. Jonathan Rosenberg (39)
  5. David Solit (33)
  6. Gopakumar Iyer (33)

More People

Years
  1. 2025 (9)
  2. 2024 (31)
  3. 2023 (12)
  4. 2022 (18)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. European Journal of Cancer (96)
  2. Clinical Genitourinary Cancer (63)
  3. Urologic Oncology: Seminars and Original Investigations (49)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Seminars in Oncology (41)
  6. Hematology/Oncology Clinics of North America (10)

More Publications

Results (384)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
    Journal Article

    Lee, C. H.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy
    Journal Article

    Haas, G. P.; Scher, H. I.
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • Incomplete cross-resistance between taxanes for advanced urothelial carcinoma: Implications for clinical practice and trial design
    Journal Article

    Sonpavde, G.; Pond, G. R.; Mullane, S.; Qu, A. Q.; di Lorenzo, G.; Federico, P.; Necchi, A.; Rosenberg, J. E.; Bellmunt, J.; Choueiri, T. K.
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval
    Journal Article

    Haas, G. P.; Scher, H. I.
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward
    Journal Article

    Apolo, A. B.; Hoffman, V.; Kaag, M. G.; Latini, D. M.; Lee, C. T.; Rosenberg, J. E.; Knowles, M.; Theodorescu, D.; Czerniak, B. A.; Efstathiou, J. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma
    Journal Article

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: Implications for trial design
    Journal Article

    Pond, G. R.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis
    Journal Article

    Bastos, D. A.; Molina, A. M.; Hatzoglou, V.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
    Journal Article

    Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Hansen, M.; Edenbrandt, L.; Forsberg, G.; Nordle, T.; Pili, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2014)

    Fulltext@MSK | Save
  • Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
    Journal Article

    Milowsky, M. I.; Dittrich, C.; Durán, I.; Jagdev, S.; Millard, F. E.; Sweeney, C. J.; Bajorin, D.; Cerbone, L.; Quinn, D. I.; Stadler, W. M.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save